GlaxoSmithKline Pharma's Q1 FY26: Flat Revenue, Explosive Profit Growth. Unpacking Their Strategic Pivot.

Discover how GSK Pharma defied expectations in Q1 FY26, turning flat revenue into a stunning profit …